buthionine sulfoximine has been researched along with Cognitive Decline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanco, L; Fernández, CI; Fernández, JL; González-Fraguela, ME; Lorigados, L; Serrano, T | 1 |
| Dépré, M; Gisquet-Verrier, P; Preissmann, D; Schenk, F | 1 |
2 other study(ies) available for buthionine sulfoximine and Cognitive Decline
| Article | Year |
|---|---|
Glutathione depletion: Starting point of brain metabolic stress, neuroinflammation and cognitive impairment in rats.
Topics: Animals; Avoidance Learning; Brain; Brain Diseases; Buthionine Sulfoximine; Cognitive Dysfunction; Disease Models, Animal; Glutathione; Inflammation; Male; Maze Learning; Oxidative Stress; Random Allocation; Rats, Sprague-Dawley; Reactive Oxygen Species; Spatial Memory; Tumor Necrosis Factor-alpha | 2018 |
Anxiety modulates cognitive deficits in a perinatal glutathione deficit animal model of schizophrenia.
Topics: Animals; Anxiety; Avoidance Learning; Behavior, Animal; Buthionine Sulfoximine; Cognitive Dysfunction; Disease Models, Animal; Glutathione; Locomotion; Male; Prepulse Inhibition; Rats; Rats, Wistar; Reflex, Startle; Schizophrenia; Schizophrenic Psychology | 2016 |